Marketing and Distribution

• Countries served directly by in-house commercial operations currently represent over 80% of the Company’s yearly product sales revenues.
• Valneva has also continued to utilize its commercial organization to distribute third-party products, such as typhoid and influenza vaccines, and aims to further leverage its commercial infrastructure.
• To ensure broad geographic access to IXIARO® and DUKORAL®, Valneva has partnered with leading global and local players through country-specific marketing and distribution agreements in countries where the Company doesn’t operate its own sales and marketing activities.

Select your country to learn more:

• Valneva Austria
• Valneva Canada
• Valneva Nordic
• Valneva UK
• Valneva U.S.